Year: 2015
Type: article
Abstract: The NCCN Guidelines for Myelodysplastic Syndromes (MDS) comprise a heterogeneous group of myeloid disorders with a highly variable disease course that depends largely on risk factors. Risk evaluation is therefore a critical component of decision-making in the treatment of MDS. The development of newer treatments and the refinement of current treatment modalities are designed to improve patient outcomes and reduce side effects. These NCCN Guidelines Insights focus on the recent updates to the guidelines, which include the incorporation of a revised prognostic scoring system, addition of molecular abnormalities associated with MDS, and refinement of treatment options involving a discussion of cost of care.
Authors: Peter L. Greenberg, Richard M. Stone, Rafael Bejar, John M. Bennett, Clara D. Bloomfield, Uma Borate, Carlos M. De Castro, H. Joachim Deeg, Amy E. DeZern, Amir T. Fathi, Olga Frankfurt, Karin Gaensler, Guillermo Garcia-Manero, Elizabeth A. Griffiths, David Head, Virginia Klimek, Rami Komrokji, Lisa A. Kujawski, Lori J. Maness, Margaret R. O’Donnell, Daniel A. Pollyea, Bart Scott, Paul J. Shami, Brady L. Stein, Peter Westervelt, Benton Wheeler, Dorothy A. Shead, Courtney Smith
Institutions: The University of Texas MD Anderson Cancer Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, University of Rochester Medicine, University of Alabama at Birmingham, Dana-Farber Brigham Cancer Center, UCSF Helen Diller Family Comprehensive Cancer Center, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Moores Cancer Center, Duke Cancer Institute, Stanford University, University of Rochester, The Ohio State University, Duke University, Seattle Cancer Care Alliance, Johns Hopkins University, Harvard University, Northwestern University, University of California, San Francisco, Roswell Park Comprehensive Cancer Center, Vanderbilt University, Memorial Sloan Kettering Cancer Center, University of South Florida, University of Michigan, Fred and Pamela Buffett Cancer Center, City Of Hope National Medical Center, City of Hope, University of Colorado Cancer Center, University of Utah, Washington University in St. Louis, University of Tennessee Health Science Center, National Comprehensive Cancer Network
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2108397210